Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

ALTIMMUNE Earnings Results: $ALT Reports Quarterly Earnings

None

ALTIMMUNE ($ALT) posted quarterly earnings results on Thursday, November 6th. The company reported earnings of -$0.21 per share, beating estimates of -$0.28 by $0.07. The company also reported revenue of $10,000, beating estimates of $1,262 by $8,738.

You can see Quiver Quantitative's $ALT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

ALTIMMUNE Hedge Fund Activity

We have seen 92 institutional investors add shares of ALTIMMUNE stock to their portfolio, and 87 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • AMERIPRISE FINANCIAL INC removed 1,330,057 shares (-92.1%) from their portfolio in Q2 2025, for an estimated $5,147,320
  • MARSHALL WACE, LLP removed 1,146,238 shares (-98.1%) from their portfolio in Q2 2025, for an estimated $4,435,941
  • BELLEVUE GROUP AG removed 1,056,793 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,089,788
  • MILLENNIUM MANAGEMENT LLC removed 1,033,005 shares (-93.0%) from their portfolio in Q2 2025, for an estimated $3,997,729
  • SCHRODER INVESTMENT MANAGEMENT GROUP removed 961,884 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,722,491
  • CAPTION MANAGEMENT, LLC added 941,917 shares (+2423.6%) to their portfolio in Q2 2025, for an estimated $3,645,218
  • FEDERATED HERMES, INC. removed 915,383 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,450,993

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ALTIMMUNE Analyst Ratings

Wall Street analysts have issued reports on $ALT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 10/10/2025
  • UBS issued a "Buy" rating on 08/13/2025

To track analyst ratings and price targets for ALTIMMUNE, check out Quiver Quantitative's $ALT forecast page.

ALTIMMUNE Price Targets

Multiple analysts have issued price targets for $ALT recently. We have seen 5 analysts offer price targets for $ALT in the last 6 months, with a median target of $15.0.

Here are some recent targets:

  • Patrick R. Trucchio from HC Wainwright & Co. set a target price of $12.0 on 10/20/2025
  • Mayank Mamtani from B. Riley Securities set a target price of $18.0 on 08/13/2025
  • Eliana Merle from UBS set a target price of $24.0 on 08/13/2025
  • Jonathan Wolleben from JMP Securities set a target price of $15.0 on 07/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles